Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $594.06 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Enterra Medical, Inc. | $145.37 | 1 | $0 (2024) |
| PFIZER INC. | $130.16 | 4 | $0 (2018) |
| ABBVIE INC. | $129.97 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $114.36 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $26.36 | 2 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $16.90 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.50 | 1 | $0 (2018) |
| QOL Medical, LLC | $15.44 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.90 | 4 | Enterra Medical, Inc. ($145.37) |
| 2019 | $27.79 | 2 | QOL Medical, LLC ($15.44) |
| 2018 | $269.42 | 9 | PFIZER INC. ($130.16) |
| 2017 | $91.95 | 1 | AbbVie, Inc. ($91.95) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $145.37 | General |
| 03/14/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Gastroenterology | ||||||
| 07/11/2019 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/11/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/06/2018 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological), RENFLEXIS | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/28/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $100.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/17/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/15/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Immunology | ||||||
| 06/11/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $90.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/01/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: INFLAMMATION | ||||||
| 02/23/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Virology | ||||||
| 02/09/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: INFLAMMATION | ||||||
| 01/02/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $91.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 346 | 369 | $205,260 | $35,941 |
| 2022 | 9 | 334 | 363 | $151,410 | $32,664 |
| 2021 | 11 | 338 | 370 | $122,702 | $33,277 |
| 2020 | 10 | 421 | 502 | $166,232 | $40,290 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 14 | 14 | $17,668 | $2,791 | 15.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 21 | 21 | $19,684 | $2,138 | 10.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 34 | $4,794 | $2,043 | 42.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 27 | 27 | $16,854 | $1,633 | 9.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $4,304 | $1,587 | 36.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 16 | $3,264 | $1,206 | 36.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,508 | $873.40 | 34.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 75 | 75 | $24,075 | $8,700 | 36.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 51 | $20,196 | $8,063 | 39.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 69 | 110 | $15,620 | $6,348 | 40.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 75 | $15,600 | $5,345 | 34.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 38 | 39 | $34,580 | $4,112 | 11.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 44 | 44 | $28,788 | $2,804 | 9.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 13 | 14 | $16,406 | $2,229 | 13.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 20 | 45 | $5,670 | $956.24 | 16.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 23 | $3,243 | $919.46 | 28.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 26 | $2,054 | $811.85 | 39.5% |
About Dr. Rebecca Rawl, MD
Dr. Rebecca Rawl, MD is a Gastroenterology healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467778555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Rawl, MD has received a total of $594.06 in payments from pharmaceutical and medical device companies, with $204.90 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($594.06).
As a Medicare-enrolled provider, Rawl has provided services to 1,439 Medicare beneficiaries, totaling 1,604 services with total Medicare billing of $142,173. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location Huntersville, NC
- Active Since 04/14/2010
- Last Updated 06/17/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1467778555
Products in Payments
- XELJANZ (Drug) $110.16
- DIFICID (Drug) $102.79
- RINVOQ (Biological) $27.08
- INFLECTRA (Biological) $20.00
- Bylvay (Drug) $16.90
- TREMFYA (Drug) $15.55
- XIFAXAN (Drug) $15.50
- Sucraid (Drug) $15.44
- ZINPLAVA (Biological) $11.57
- Mavyret (Drug) $10.94
- STELARA (Biological) $10.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntersville
Dr. Maria Hatara, Md, MD
Gastroenterology — Payments: $8,938
Sharad Nangia, M.d, M.D
Gastroenterology — Payments: $954.45
Dr. Scott Brotze, M.d, M.D
Gastroenterology — Payments: $930.52
Caroline Barrett, M.d, M.D
Gastroenterology — Payments: $728.64
Dr. Devi Thangavelu, M.d, M.D
Gastroenterology — Payments: $693.27
Dr. Steven Josephson, M.d, M.D
Gastroenterology — Payments: $670.16